Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lacosamide for children with paroxysmal kinesigenic dyskinesia.

Brain & development - 1 Sept 2020

Furukawa Gen, Negishi Yutaka, Takeuchi Tomoya, Ishihara Naoko, Okumura Akihisa

Abstract excerpt

OBJECTIVES: This study was performed to evaluate the efficacy and tolerability of lacosamide (LCM) for paroxysmal kinesigenic dyskinesia (PKD) in children. METHODS: We retrospectively reviewed the medical charts of pediatric PKD patients (aged <16 years) treated with LCM. Data regarding demographic characteristics, proline-rich transmembrane protein 2 (PRRT2) gene variant, clinical features of PKD, dose of LCM,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Carbamazepine
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dystonia

Share to Membrane Proteins

Share to Mutation

Share to Nerve Tissue Proteins

Source

Identifiers

PMID: 32430160
DOI: 10.1016/j.braindev.2020.04.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lacosamide for children with paroxysmal kinesigenic dyskinesia.PMID 32430160Read ↗

Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.Semantic proximity Read ↗

[Clinical manifestations and genetic diagnosis of paroxysmal kinesigenic dyskinesia].Semantic proximity Read ↗

Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients.Semantic proximity Read ↗

Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.Semantic proximity Read ↗

Paroxysmal Kinesigenic Dyskinesia in Two Siblings With Novel Heterozygous TMEM151A Frameshift Variant: The First Case Report in Japan.Semantic proximity Read ↗

Phenotypes, genotypes, and the management of paroxysmal movement disorders.Semantic proximity Read ↗

Paroxysmal kinesigenic dyskinesia associated with a novel POLG variant: A case report.Semantic proximity Read ↗

Effective Treatment of Paroxysmal Nonkinesigenic Dyskinesia With Oxcarbazepine.Semantic proximity Read ↗

PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population.Semantic proximity Read ↗

Paroxysmal dyskinesiasSemantic proximity Read ↗

Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria.Semantic proximity Read ↗

PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.